Mechanism of Action
Schisandra's active lignans, particularly schisandrin B and schisandrin C, operate through multiple hepatoprotective mechanisms. They reduce lipid peroxidation in hepatocyte membranes, protecting liver cells from oxidative damage. They upregulate hepatic glutathione synthesis, increasing the liver's primary endogenous antioxidant capacity. They reduce activation of NF-kB, a master regulator of hepatic inflammation, lowering the production of TNF-alpha and IL-6 in liver tissue. They also stimulate hepatocyte proliferation through effects on growth factor signalling, supporting the liver's capacity for tissue regeneration after injury.
Evidence Summary
Schisandra has been studied extensively in animal models of chemically induced liver injury. A review published in Molecules (2012) documented schisandrin B's protective effects against carbon tetrachloride, paracetamol and thioacetamide-induced liver damage in rodent models, with significant reductions in ALT and AST enzyme levels. A 2019 study in the Journal of Ethnopharmacology confirmed hepatoprotective and antifibrotic effects of schisandrin B in a high-fat diet rodent model. Petz Park's direct comparison to Hepatoadvanced and Denamarin on their product page is honest and accurate: Schisandra provides hepatoprotection through a complementary pathway to SAMe.
In Petz Park Products
Liver Support for Dogs: Schisandra Chinensis 220mg per scoop. Liver Support for Cats: Schisandra Chinensis Extract 50mg per scoop.
Safety and Considerations
Schisandra is well tolerated at supplemental doses in dogs and cats. It may modestly affect the hepatic metabolism of some drugs processed through CYP3A4 pathways. Veterinary oversight is recommended for animals with diagnosed liver disease receiving prescription hepatic treatments.